We found that tumor size in mice injected with GATA6- or TET1-depleted CAFs were ~20% smaller than those in the control group (Mice transplanted with scramble siRNA-transfected CAFs) (P < 0.05; Fig. 6A). The gene discussed is GATA6; the disease is neoplasm.